Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

AFC-HD AMS Life Science Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	n/a
Yönetim ortalama görev süresi	22.1yrs
Yönetim Kurulu ortalama görev süresi	3.9yrs

Son yönetim güncellemeleri

Recent updates

AFC-HD AMS Life Science (TSE:2927) Is Due To Pay A Dividend Of ¥15.00

Apr 17

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Might Deserve Your Attention Today

Apr 29

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Safely

Apr 14

AFC-HD AMS Life Science Co., Ltd.'s (TYO:2927) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 09

Is It Smart To Buy AFC-HD AMS Life Science Co., Ltd. (TYO:2927) Before It Goes Ex-Dividend?

Feb 20

The Trends At AFC-HD AMS Life Science (TYO:2927) That You Should Know About

Feb 04

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Is An Interesting Stock

Jan 17

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Reasonably Well

Dec 29

AFC-HD AMS Life Science Co., Ltd. (TYO:2927) On An Uptrend: Could Fundamentals Be Driving The Stock?

Dec 02

CEO

AFC-HD AMS Life Science CEO'su yok ya da onlar hakkında elimizde veri yok.

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Nobue Hamabe	Accounting Manager & Director	22.1yrs	Veri yok	0.17% ¥ 19.7m
Naoya Unno	GM of Technical Development Division & Director	22.1yrs	Veri yok	0.23% ¥ 27.3m
Shigenori Fukuchi	Senior MD	18.9yrs	Veri yok	0.29% ¥ 33.9m

22.1yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: 2927 'un yönetim ekibi deneyimli ve deneyimlidir ( 22.1 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Nobue Hamabe	Accounting Manager & Director	1.9yrs	Veri yok	0.17% ¥ 19.7m
Naoya Unno	GM of Technical Development Division & Director	21.1yrs	Veri yok	0.23% ¥ 27.3m
Shigenori Fukuchi	Senior MD	21.1yrs	Veri yok	0.29% ¥ 33.9m
Takehiko Asayama	Chairman	23.3yrs	JP¥234.60m	8.41% ¥ 976.3m
Hiroshi Unno	Independent Outside Director	3.9yrs	Veri yok	0.022% ¥ 2.6m
Shigeo Minakata	Director	2.9yrs	Veri yok	0.041% ¥ 4.7m
Shunji Sasahara	Director	3.9yrs	Veri yok	0.036% ¥ 4.1m

3.9yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 2927 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.9 yıldır).

AFC-HD AMS Life Science Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 28, 2023

No independent directors

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 29, 2022

No independent directors

Recent updates

New major risk - Financial data availability

Upcoming dividend of JP¥15.00 per share

AFC-HD AMS Life Science Co., Ltd. to Report Fiscal Year 2024 Results on Oct 15, 2024

Investor sentiment deteriorates as stock falls 16%

AFC-HD AMS Life Science Co., Ltd. (TSE:2927) agreed to acquire Rabbit Kyuko K.K. from Shinichi Matsunaga for ¥1.

Third quarter 2024 earnings released: EPS: JP¥19.98 (vs JP¥19.05 in 3Q 2023)

AFC-HD AMS Life Science Co., Ltd. to Report Q3, 2024 Results on Jul 16, 2024

AFC-HD AMS Life Science (TSE:2927) Is Due To Pay A Dividend Of ¥15.00

First half dividend of JP¥15.00 announced

Second quarter 2024 earnings released: EPS: JP¥22.99 (vs JP¥18.05 in 2Q 2023)

AFC-HD AMS Life Science Co., Ltd. to Report Q2, 2024 Results on Apr 15, 2024

Upcoming dividend of JP¥15.00 per share

First quarter 2024 earnings released: EPS: JP¥22.76 (vs JP¥11.40 in 1Q 2023)

AFC-HD AMS Life Science Co., Ltd. to Report Q1, 2024 Results on Jan 12, 2024

Full year 2023 earnings released: EPS: JP¥77.12 (vs JP¥52.31 in FY 2022)

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 28, 2023

Upcoming dividend of JP¥15.00 per share at 3.0% yield

AFC-HD AMS Life Science Co., Ltd. to Report Fiscal Year 2023 Results on Oct 13, 2023

Third quarter 2023 earnings released: EPS: JP¥19.05 (vs JP¥16.25 in 3Q 2022)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023

AFC-HD AMS Life Science Co., Ltd. (TSE:2927) announces an Equity Buyback for 100,000 shares, representing 0.71% for ¥100 million.

AFC-HD AMS Life Science Co., Ltd. to Report Q3, 2023 Results on Jul 14, 2023

Second quarter 2023 earnings released: EPS: JP¥18.05 (vs JP¥10.79 in 2Q 2022)

Upcoming dividend of JP¥12.50 per share at 3.1% yield

AFC-HD AMS Life Science Co., Ltd. to Report Q2, 2023 Results on Apr 14, 2023

Investor sentiment improves as stock rises 16%

First quarter 2023 earnings released: EPS: JP¥11.40 (vs JP¥11.03 in 1Q 2022)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023

AFC-HD AMS Life Science Co., Ltd. (TSE:2927) agreed to acquire a 51% stake in 5SPRO Joint Stock Company.

Full year 2022 earnings released: EPS: JP¥52.31 (vs JP¥107 in FY 2021)

AFC-HD AMS Life Science Co., Ltd. to Report Q1, 2023 Results on Jan 13, 2023

No independent directors

Full year 2022 earnings released: EPS: JP¥52.31 (vs JP¥107 in FY 2021)

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 29, 2022

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023

AFC-HD AMS Life Science Co., Ltd. to Report Fiscal Year 2022 Results on Oct 14, 2022

Upcoming dividend of JP¥15.00 per share

Third quarter 2022 earnings released: EPS: JP¥16.25 (vs JP¥45.13 in 3Q 2021)

AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Period Ending August 2022

AFC-HD AMS Life Science Co., Ltd. to Report Q3, 2022 Results on Jul 15, 2022

No independent directors

AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Second Quarter of 2022, Payable on May 16, 2022

Second quarter 2022 earnings released: EPS: JP¥10.79 (vs JP¥25.92 in 2Q 2021)

AFC-HD AMS Life Science Co., Ltd. to Report Q2, 2022 Results on Apr 14, 2022

Upcoming dividend of JP¥15.00 per share

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: EPS JP¥107 (vs JP¥48.07 in FY 2020)

Upcoming dividend of JP¥15.00 per share

Third quarter 2021 earnings released: EPS JP¥45.13 (vs JP¥6.33 in 3Q 2020)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 2021

Investor sentiment improved over the past week

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Might Deserve Your Attention Today

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Safely

Second quarter 2021 earnings released: EPS JP¥25.92 (vs JP¥13.58 in 2Q 2020)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending August 2021

AFC-HD AMS Life Science Co., Ltd.'s (TYO:2927) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Is It Smart To Buy AFC-HD AMS Life Science Co., Ltd. (TYO:2927) Before It Goes Ex-Dividend?

New 90-day high: JP¥1,115

The Trends At AFC-HD AMS Life Science (TYO:2927) That You Should Know About

New 90-day high: JP¥1,088

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Is An Interesting Stock

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥26.88

New 90-day high: JP¥798

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Reasonably Well

AFC-HD AMS Life Science Co., Ltd. (TYO:2927) On An Uptrend: Could Fundamentals Be Driving The Stock?

AFC-HD AMS Life Science Co., Ltd. Announces Year End Dividend for the Fiscal Year Ended August 31, 2020, Payable on November 26, 2020

Full year earnings released - EPS JP¥48.07

New 90-day low - JP¥674

Upcoming Dividend of JP¥10.00 Per Share